Botanix Pharmaceuticals Limited BXPHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.98M | -12.69M | -10.89M | -10.86M | -17.78M |
| Total Depreciation and Amortization | 401.20K | 392.20K | 389.30K | 388.10K | 367.00K |
| Total Amortization of Deferred Charges | 871.00K | 851.50K | -- | -- | 1.64M |
| Total Other Non-Cash Items | 2.52M | 2.46M | 570.60K | 568.80K | 6.85M |
| Change in Net Operating Assets | -2.99M | -2.92M | -- | -- | -6.45M |
| Cash from Operations | -12.19M | -11.91M | -9.93M | -9.90M | -15.38M |
| Capital Expenditure | 800.00 | 800.00 | -700.00 | -700.00 | -62.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.80K | 10.50K | -144.20K | -143.70K | 0.00 |
| Cash from Investing | 11.60K | 11.30K | -144.90K | -144.50K | -62.70K |
| Total Debt Issued | -- | -- | -- | -- | 14.20M |
| Total Debt Repaid | -1.41M | -1.41M | -103.00K | -103.00K | -65.50K |
| Issuance of Common Stock | 22.50M | 22.50M | 10.50K | 10.50K | 20.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.53M | -1.53M | -1.18M | -1.18M | -1.65M |
| Cash from Financing | 13.89M | 13.58M | -838.40K | -835.80K | 20.81M |
| Foreign Exchange rate Adjustments | 64.10K | 62.70K | -28.60K | -28.50K | -66.60K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 1.78M | 1.74M | -10.95M | -10.91M | 5.29M |